Literature DB >> 30917995

Prediction Models for AKI: Will They Result in Improved Outcomes for AKI?

Yuenting Diana Kwong1, Kathleen D Liu2,3.   

Abstract

Keywords:  Acute Kidney Injury; risk factors

Mesh：

Substances：

Year:  2019        PMID： 30917995      PMCID： PMC6450360          DOI： 10.2215/CJN.02250219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  8 in total

1.  Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

Authors:  Carolyn S Calfee; Kevin Delucchi; Polly E Parsons; B Taylor Thompson; Lorraine B Ware; Michael A Matthay
Journal:  Lancet Respir Med       Date:  2014-05-19       Impact factor: 30.700

2.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.

Authors:  Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

3.  New Strategies for Effective Therapeutics in Critically Ill Patients.

Authors:  Michael A Matthay; Kathleen D Liu
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 4.  Paradigms of acute kidney injury in the intensive care setting.

Authors:  John A Kellum; John R Prowle
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

5.  A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data.

Authors:  Pavan Kumar Bhatraju; Leila R Zelnick; Ronit Katz; Carmen Mikacenic; Susanna Kosamo; William O Hahn; Victoria Dmyterko; Bryan Kestenbaum; David C Christiani; W Conrad Liles; Jonathan Himmelfarb; Mark M Wurfel
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-27       Impact factor: 8.237

6.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Authors:  Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2018-08-02       Impact factor: 30.700

Review 7.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

8.  Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.

Authors:  Pavan K Bhatraju; Leila R Zelnick; Jerald Herting; Ronit Katz; Carmen Mikacenic; Susanna Kosamo; Eric D Morrell; Cassianne Robinson-Cohen; Carolyn S Calfee; Jason D Christie; Kathleen D Liu; Michael A Matthay; William O Hahn; Victoria Dmyterko; Natalie S J Slivinski; Jim A Russell; Keith R Walley; David C Christiani; W Conrad Liles; Jonathan Himmelfarb; Mark M Wurfel
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.